Alcon's aspheric IOL (intraocular lens)
This article was originally published in Clinica
The US FDA has given Alcon Laboratories approval to market its AcrySof ReSTOR apodised diffractive aspheric intraocular lens (IOL) for the visual correction of aphakia following cataract surgery in adults with and without presbyopia. The product is the only FDA-approved presbyopia-correcting IOL that incorporates aspheric optics into its design, claimed the firm, a subsidiary of Fort Worth, Texas-based Alcon. A phased commercial launch of the lens will begin after necessary consignment quantities are established, with full distribution expected by the middle of the year.